Inhaled Treprostinil after Initial Clinical Worsening: To Continue or Not to Continue, That's the Question.

The article presents a study to comprehensively evaluate the effect of continued inhaled treprostinil on multiple disease progression events. It demonstrated ongoing benefit from the continued inhalation therapy despite evidence of clinical worsening in patients with PH-ILD, providing constructive guidance for real-world clinical practice in the event of disease progression.